Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

about

Albiglutide efficacy and safety in the Latino/Hispanic subpopulation for the integrated phase III program.

P2860

Q47588862-56F7CF1D-5517-4F50-A8EC-497E95033AE1

P2860

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

Item

http://www.wikidata.org/entity/Q53988383

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@en

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@nl

type

Item

label

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@en

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@nl

prefLabel

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@en

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@nl

P1476

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

@en

P2093

José E Rodríguez

http://www.w3.org/2001/XMLSchema#string

P2860

Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis

Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.

Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.

The contribution of biogeographical ancestry and socioeconomic status to racial/ethnic disparities in type 2 diabetes mellitus: results from the Boston Area Community Health Survey

Differing effects of metformin on glycemic control by race-ethnicity.

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

Long term cardiovascular effects of oral antidiabetic agents in non-diabetic patients with insulin resistance: double blind, prospective, randomised study.

Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study.

Physical activity participation, health perceptions, and cardiovascular disease mortality in a multiethnic population: the Dallas Heart Study.

Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus.

P304

66-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/CD15-0048

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

K Campbell

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28144049

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5241767

http://www.w3.org/2001/XMLSchema#string

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

about

P2860

P2860

Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932